We are live on ! Find out more
TVGN icon

Tevogen Inc. Common Stock
TVGN

56 hedge funds and large institutions have $6.04M invested in Tevogen Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 12

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

45% more capital invested

Capital invested by funds: $4.16M → $6.04M (+$1.88M)

8% more funds holding

Funds holding: 52 → 56 (+4)

0.01% more ownership

Funds ownership: 0.04% → 0.05% (+0.01%)

Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
24
Reduced
12
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$724K
2
Morgan Stanley
Morgan Stanley
New York
+$94.6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$63.4K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$57.3K
5
BCM
Bridgeway Capital Management
Texas
+$56.4K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$117K
2
XT
XTX Topco
Cayman Islands
-$63.5K
3
JP Morgan Chase
JP Morgan Chase
New York
-$57.5K
4
CF
Corebridge Financial
Texas
-$12.3K
5
SP
SIH Partners
Delaware
-$11.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$1.84M +$724K +12,716 +76%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.36M +$57.3K +1,006 +5%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$678K +$63.4K +1,113 +11%
Northern Trust
4
Northern Trust
Illinois
$241K +$39.4K +691 +22%
Morgan Stanley
5
Morgan Stanley
New York
$186K +$94.6K +1,660 +126%
State Street
6
State Street
Massachusetts
$180K +$37K +649 +29%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$134K -$1.48K -26 -1%
N
8
Nuveen
North Carolina
$113K – – –
SEI Investments
9
SEI Investments
Pennsylvania
$113K – – –
UBS Group
10
UBS Group
Switzerland
$101K -$117K -2,055 -56%
Goldman Sachs
11
Goldman Sachs
New York
$100K +$28.9K +507 +46%
Charles Schwab
12
Charles Schwab
California
$95.6K +$30.6K +537 +54%
Barclays
13
Barclays
United Kingdom
$85.7K +$34.8K +611 +80%
Creative Planning
14
Creative Planning
Kansas
$62.5K – – –
BCM
15
Bridgeway Capital Management
Texas
$61.9K +$56.4K +990 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$58.8K +$29K +509 +118%
CUAMC
17
China Universal Asset Management Company
China
$46.2K +$2.11K +37 +5%
Deutsche Bank
18
Deutsche Bank
Germany
$44.3K +$40.4K +709 New
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$43K +$7.46K +131 +24%
Jane Street
20
Jane Street
New York
$36.1K +$32.9K +578 New
AQR Capital Management
21
AQR Capital Management
Connecticut
$35.1K +$1.94K +34 +6%
AllianceBernstein
22
AllianceBernstein
Tennessee
$32.3K +$29.5K +517 New
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$28.8K -$7.35K -129 -22%
JP Morgan Chase
24
JP Morgan Chase
New York
$28.8K -$57.5K -1,009 -69%
TSS
25
Two Sigma Securities
New York
$27.1K +$24.7K +434 New
1
2 3

TVGN Hedge Fund Activity: Q2 2025 in Review

56 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q2 2025, worth a combined $6.04M — up 45% from $4.16M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TVGN positions and 5 closed out — a net gain of 4 holders — while 24 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $724K. The largest seller was UBS Group, cutting an estimated $117K.

  • 56 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q2 2025, up from 52 in Q1 2025.
  • Funds reported $6.04M of Tevogen Inc. Common Stock stock for Q2 2025, up 45% quarter-over-quarter.
  • 9 funds opened new Tevogen Inc. Common Stock positions in Q2 2025 and 5 closed out, a net change of +4 holders.
  • The largest Tevogen Inc. Common Stock buyer in Q2 2025 was BlackRock, an estimated $724K added.
  • The largest Tevogen Inc. Common Stock seller in Q2 2025 was UBS Group, an estimated $117K sold.

Based on aggregated 13F filings for Q2 2025.